

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.58773993 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.58773993 |
| 3 | L-amino acid import (GO:0043092) | 5.29257055 |
| 4 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.85093100 |
| 5 | C4-dicarboxylate transport (GO:0015740) | 4.83706460 |
| 6 | amino acid import (GO:0043090) | 4.68305902 |
| 7 | alanine transport (GO:0032328) | 4.39805194 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 4.38365744 |
| 9 | cellular potassium ion homeostasis (GO:0030007) | 4.37024317 |
| 10 | locomotory exploration behavior (GO:0035641) | 4.34162095 |
| 11 | presynaptic membrane assembly (GO:0097105) | 4.25986973 |
| 12 | gamma-aminobutyric acid transport (GO:0015812) | 4.13041806 |
| 13 | auditory behavior (GO:0031223) | 4.11948128 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.11650838 |
| 15 | presynaptic membrane organization (GO:0097090) | 4.05773297 |
| 16 | response to auditory stimulus (GO:0010996) | 4.03751295 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 3.99942617 |
| 18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.96907894 |
| 19 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.96774664 |
| 20 | negative regulation of astrocyte differentiation (GO:0048712) | 3.96552258 |
| 21 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.94803002 |
| 22 | regulation of beta-amyloid formation (GO:1902003) | 3.92709918 |
| 23 | vocalization behavior (GO:0071625) | 3.88183064 |
| 24 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.86878804 |
| 25 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.84342515 |
| 26 | L-serine transport (GO:0015825) | 3.83668500 |
| 27 | positive regulation of synapse maturation (GO:0090129) | 3.75852120 |
| 28 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.75423809 |
| 29 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.75333018 |
| 30 | synaptic vesicle exocytosis (GO:0016079) | 3.74192862 |
| 31 | neuronal action potential propagation (GO:0019227) | 3.73609940 |
| 32 | response to histamine (GO:0034776) | 3.73323667 |
| 33 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.68207703 |
| 34 | glutamate secretion (GO:0014047) | 3.66424734 |
| 35 | synaptic transmission, glutamatergic (GO:0035249) | 3.63971521 |
| 36 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.62182778 |
| 37 | sodium ion export (GO:0071436) | 3.61921131 |
| 38 | postsynaptic membrane organization (GO:0001941) | 3.61149311 |
| 39 | transmission of nerve impulse (GO:0019226) | 3.61102876 |
| 40 | neurotransmitter uptake (GO:0001504) | 3.59127552 |
| 41 | mechanosensory behavior (GO:0007638) | 3.58789717 |
| 42 | protein localization to synapse (GO:0035418) | 3.57130112 |
| 43 | * glutamate receptor signaling pathway (GO:0007215) | 3.55007743 |
| 44 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.54984204 |
| 45 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.54722337 |
| 46 | neurotransmitter transport (GO:0006836) | 3.45486730 |
| 47 | positive regulation of synapse assembly (GO:0051965) | 3.39341467 |
| 48 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.38946386 |
| 49 | membrane depolarization during action potential (GO:0086010) | 3.38295289 |
| 50 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.38055627 |
| 51 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.37858527 |
| 52 | startle response (GO:0001964) | 3.36778996 |
| 53 | proline transport (GO:0015824) | 3.36594853 |
| 54 | synaptic vesicle maturation (GO:0016188) | 3.33185883 |
| 55 | neuron-neuron synaptic transmission (GO:0007270) | 3.32438291 |
| 56 | regulation of neurotransmitter levels (GO:0001505) | 3.32258727 |
| 57 | layer formation in cerebral cortex (GO:0021819) | 3.31918592 |
| 58 | positive regulation of membrane potential (GO:0045838) | 3.31806947 |
| 59 | neuronal ion channel clustering (GO:0045161) | 3.31422314 |
| 60 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.30469329 |
| 61 | glial cell proliferation (GO:0014009) | 3.30197787 |
| 62 | cerebellar granule cell differentiation (GO:0021707) | 3.27352744 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.26927550 |
| 64 | positive regulation of dendritic spine development (GO:0060999) | 3.24342760 |
| 65 | serine transport (GO:0032329) | 3.23442280 |
| 66 | membrane depolarization (GO:0051899) | 3.19283347 |
| 67 | establishment of mitochondrion localization (GO:0051654) | 3.18514635 |
| 68 | cellular sodium ion homeostasis (GO:0006883) | 3.16859907 |
| 69 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.16638709 |
| 70 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.16064491 |
| 71 | neuromuscular synaptic transmission (GO:0007274) | 3.16004081 |
| 72 | acidic amino acid transport (GO:0015800) | 3.15989582 |
| 73 | oligodendrocyte differentiation (GO:0048709) | 3.15487405 |
| 74 | cellular response to cholesterol (GO:0071397) | 3.15464244 |
| 75 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.14582581 |
| 76 | exploration behavior (GO:0035640) | 3.12356457 |
| 77 | regulation of synapse maturation (GO:0090128) | 3.10238610 |
| 78 | potassium ion import (GO:0010107) | 3.10112535 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.09915167 |
| 80 | cell communication by electrical coupling (GO:0010644) | 3.09252600 |
| 81 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.08577510 |
| 82 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.07699796 |
| 83 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.06006046 |
| 84 | neuromuscular process controlling balance (GO:0050885) | 3.05923733 |
| 85 | * regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.05882953 |
| 86 | regulation of synapse structural plasticity (GO:0051823) | 3.04977163 |
| 87 | chondroitin sulfate catabolic process (GO:0030207) | 3.04921714 |
| 88 | long-term memory (GO:0007616) | 3.03804823 |
| 89 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.98869091 |
| 90 | dendrite morphogenesis (GO:0048813) | 2.98653114 |
| 91 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.98269783 |
| 92 | cochlea development (GO:0090102) | 2.97752175 |
| 93 | synaptic vesicle endocytosis (GO:0048488) | 2.96502711 |
| 94 | neuron recognition (GO:0008038) | 2.96262877 |
| 95 | long-term synaptic potentiation (GO:0060291) | 2.95156335 |
| 96 | * synaptic transmission (GO:0007268) | 2.95120138 |
| 97 | prepulse inhibition (GO:0060134) | 2.94726290 |
| 98 | myelination in peripheral nervous system (GO:0022011) | 2.94626148 |
| 99 | peripheral nervous system axon ensheathment (GO:0032292) | 2.94626148 |
| 100 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.93737708 |
| 101 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.92644890 |
| 102 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.92543106 |
| 103 | dendritic spine morphogenesis (GO:0060997) | 2.91919439 |
| 104 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.91612892 |
| 105 | myelination (GO:0042552) | 2.91579764 |
| 106 | potassium ion homeostasis (GO:0055075) | 2.91207282 |
| 107 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.90472309 |
| 108 | nucleobase catabolic process (GO:0046113) | 2.87647240 |
| 109 | cell differentiation in hindbrain (GO:0021533) | 2.86434404 |
| 110 | regulation of astrocyte differentiation (GO:0048710) | 2.86376043 |
| 111 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.86073331 |
| 112 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.85463984 |
| 113 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.85453501 |
| 114 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.85288881 |
| 115 | axonal fasciculation (GO:0007413) | 2.84933475 |
| 116 | behavioral defense response (GO:0002209) | 2.83941554 |
| 117 | behavioral fear response (GO:0001662) | 2.83941554 |
| 118 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.83510663 |
| 119 | axon ensheathment (GO:0008366) | 2.83296294 |
| 120 | ensheathment of neurons (GO:0007272) | 2.83296294 |
| 121 | synapse organization (GO:0050808) | 2.81695502 |
| 122 | regulation of synaptic plasticity (GO:0048167) | 2.81102211 |
| 123 | negative regulation of protein localization to cell surface (GO:2000009) | 2.80931386 |
| 124 | L-glutamate transport (GO:0015813) | 2.80633080 |
| 125 | regulation of dendritic spine development (GO:0060998) | 2.80567012 |
| 126 | adult walking behavior (GO:0007628) | 2.78391884 |
| 127 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.77248253 |
| 128 | negative regulation of neurotransmitter transport (GO:0051589) | 2.77161878 |
| 129 | negative regulation of dendrite development (GO:2000171) | 2.76668244 |
| 130 | glycine transport (GO:0015816) | 2.76560361 |
| 131 | regulation of postsynaptic membrane potential (GO:0060078) | 2.75680728 |
| 132 | neurotransmitter secretion (GO:0007269) | 2.75080441 |
| 133 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.73075160 |
| 134 | synapse assembly (GO:0007416) | 2.72734027 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.55622020 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.75448834 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07761553 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06738780 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.87479680 |
| 6 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.68863914 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.56682409 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.56682409 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.56034436 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53646326 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.52768466 |
| 12 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.51866366 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45856767 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.42526436 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.34711032 |
| 16 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23955405 |
| 17 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.20329735 |
| 18 | * AR_21572438_ChIP-Seq_LNCaP_Human | 2.17238464 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.09524981 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.04859061 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03072830 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.01887698 |
| 23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.90930027 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88848178 |
| 25 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.82390192 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.80356057 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.78063955 |
| 28 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.77809450 |
| 29 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73617393 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72120001 |
| 31 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.70900253 |
| 32 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.66541252 |
| 33 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.60667373 |
| 34 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.56060778 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55782821 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54758121 |
| 37 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.52488931 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51855977 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50014828 |
| 40 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48574268 |
| 41 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.46596713 |
| 42 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46512714 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43546775 |
| 44 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43130729 |
| 45 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42167771 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.40262238 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39699408 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.38328630 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33102372 |
| 50 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.31871950 |
| 51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30715312 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27544890 |
| 53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.27236169 |
| 54 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.26376082 |
| 55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26116776 |
| 56 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25685494 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.23319524 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22224689 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21838736 |
| 60 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21325895 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20766315 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20692012 |
| 63 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.19704998 |
| 64 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18060483 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16213340 |
| 66 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15493046 |
| 67 | RXR_22108803_ChIP-Seq_LS180_Human | 1.14874352 |
| 68 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14793236 |
| 69 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13405287 |
| 70 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.13137029 |
| 71 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12839781 |
| 72 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11669012 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11512359 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10804933 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09815342 |
| 76 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.09333515 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09329473 |
| 78 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09282946 |
| 79 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09260700 |
| 80 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.08781899 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08390144 |
| 82 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.07939879 |
| 83 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.07795390 |
| 84 | * AR_19668381_ChIP-Seq_PC3_Human | 1.07619046 |
| 85 | JUN_21703547_ChIP-Seq_K562_Human | 1.07337503 |
| 86 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.06134790 |
| 87 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05531241 |
| 88 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04885095 |
| 89 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.04571867 |
| 90 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.03939077 |
| 91 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.03446047 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01684384 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01300357 |
| 94 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01003649 |
| 95 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99870356 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99157946 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98832270 |
| 98 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98369685 |
| 99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98139982 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97774652 |
| 101 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97699912 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96616042 |
| 103 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95674285 |
| 104 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95674285 |
| 105 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95645655 |
| 106 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94017146 |
| 107 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93690662 |
| 108 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.93113810 |
| 109 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.92393519 |
| 110 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91705154 |
| 111 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.91664858 |
| 112 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.91664858 |
| 113 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.91427059 |
| 114 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91345099 |
| 115 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91095781 |
| 116 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.90494310 |
| 117 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89030918 |
| 118 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.87950755 |
| 119 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87789812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.53444019 |
| 2 | MP0003880_abnormal_central_pattern | 3.82124842 |
| 3 | MP0004270_analgesia | 3.52977394 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.39077919 |
| 5 | MP0003329_amyloid_beta_deposits | 3.15432204 |
| 6 | MP0001486_abnormal_startle_reflex | 3.15360230 |
| 7 | MP0009745_abnormal_behavioral_response | 2.91711377 |
| 8 | MP0003690_abnormal_glial_cell | 2.82786809 |
| 9 | MP0002064_seizures | 2.82267055 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.75107198 |
| 11 | MP0009046_muscle_twitch | 2.66361307 |
| 12 | * MP0002572_abnormal_emotion/affect_behav | 2.52913591 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.51428364 |
| 14 | MP0005646_abnormal_pituitary_gland | 2.43408708 |
| 15 | MP0004885_abnormal_endolymph | 2.38106066 |
| 16 | MP0002272_abnormal_nervous_system | 2.28733071 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.27994866 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.21206544 |
| 19 | MP0004858_abnormal_nervous_system | 2.18693296 |
| 20 | MP0001502_abnormal_circadian_rhythm | 2.14850635 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.11704072 |
| 22 | MP0008569_lethality_at_weaning | 2.07925405 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.03201527 |
| 24 | MP0003136_yellow_coat_color | 1.99389252 |
| 25 | MP0000778_abnormal_nervous_system | 1.97835870 |
| 26 | MP0002254_reproductive_system_inflammat | 1.95696665 |
| 27 | MP0002736_abnormal_nociception_after | 1.90455976 |
| 28 | MP0000920_abnormal_myelination | 1.88392497 |
| 29 | MP0000566_synostosis | 1.85555192 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.84675826 |
| 31 | MP0002822_catalepsy | 1.82164095 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.81141779 |
| 33 | MP0001984_abnormal_olfaction | 1.80699523 |
| 34 | MP0005171_absent_coat_pigmentation | 1.80173046 |
| 35 | MP0001529_abnormal_vocalization | 1.79333007 |
| 36 | MP0003634_abnormal_glial_cell | 1.72287936 |
| 37 | MP0003633_abnormal_nervous_system | 1.71646080 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.67468640 |
| 39 | MP0001501_abnormal_sleep_pattern | 1.67189490 |
| 40 | MP0001970_abnormal_pain_threshold | 1.65372119 |
| 41 | MP0000604_amyloidosis | 1.64268459 |
| 42 | MP0003122_maternal_imprinting | 1.62467392 |
| 43 | MP0004142_abnormal_muscle_tone | 1.58725324 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.57776699 |
| 45 | MP0004924_abnormal_behavior | 1.57776699 |
| 46 | MP0003631_nervous_system_phenotype | 1.57718177 |
| 47 | MP0003787_abnormal_imprinting | 1.51794582 |
| 48 | MP0001905_abnormal_dopamine_level | 1.47117665 |
| 49 | MP0003632_abnormal_nervous_system | 1.45492899 |
| 50 | MP0001485_abnormal_pinna_reflex | 1.43061151 |
| 51 | MP0002882_abnormal_neuron_morphology | 1.39755034 |
| 52 | MP0000955_abnormal_spinal_cord | 1.36265591 |
| 53 | MP0004742_abnormal_vestibular_system | 1.35587584 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.34772335 |
| 55 | MP0002066_abnormal_motor_capabilities/c | 1.32038242 |
| 56 | MP0002735_abnormal_chemical_nociception | 1.28678408 |
| 57 | MP0003075_altered_response_to | 1.27693522 |
| 58 | MP0005409_darkened_coat_color | 1.23025842 |
| 59 | MP0002229_neurodegeneration | 1.18549406 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.17968587 |
| 61 | MP0005645_abnormal_hypothalamus_physiol | 1.17488307 |
| 62 | MP0002184_abnormal_innervation | 1.13869505 |
| 63 | MP0002152_abnormal_brain_morphology | 1.09966239 |
| 64 | MP0001963_abnormal_hearing_physiology | 1.07920097 |
| 65 | MP0008877_abnormal_DNA_methylation | 1.03712558 |
| 66 | MP0004811_abnormal_neuron_physiology | 1.02348993 |
| 67 | MP0004043_abnormal_pH_regulation | 1.01168085 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.00452394 |
| 69 | MP0002909_abnormal_adrenal_gland | 0.99636424 |
| 70 | MP0003137_abnormal_impulse_conducting | 0.99444975 |
| 71 | MP0002090_abnormal_vision | 0.98385229 |
| 72 | MP0001177_atelectasis | 0.94988200 |
| 73 | MP0009840_abnormal_foam_cell | 0.94831380 |
| 74 | MP0001346_abnormal_lacrimal_gland | 0.93934854 |
| 75 | MP0001188_hyperpigmentation | 0.93312712 |
| 76 | MP0002638_abnormal_pupillary_reflex | 0.92705574 |
| 77 | MP0005253_abnormal_eye_physiology | 0.88373700 |
| 78 | MP0003283_abnormal_digestive_organ | 0.87906791 |
| 79 | MP0002653_abnormal_ependyma_morphology | 0.87793397 |
| 80 | MP0002752_abnormal_somatic_nervous | 0.86979106 |
| 81 | MP0000631_abnormal_neuroendocrine_gland | 0.86087701 |
| 82 | MP0004215_abnormal_myocardial_fiber | 0.85800523 |
| 83 | MP0003938_abnormal_ear_development | 0.85504927 |
| 84 | MP0000026_abnormal_inner_ear | 0.84415596 |
| 85 | MP0004147_increased_porphyrin_level | 0.83486681 |
| 86 | MP0005187_abnormal_penis_morphology | 0.82282247 |
| 87 | MP0001299_abnormal_eye_distance/ | 0.81671549 |
| 88 | MP0003861_abnormal_nervous_system | 0.80621425 |
| 89 | MP0003121_genomic_imprinting | 0.79121355 |
| 90 | MP0000049_abnormal_middle_ear | 0.77896788 |
| 91 | MP0002102_abnormal_ear_morphology | 0.76687947 |
| 92 | MP0002069_abnormal_eating/drinking_beha | 0.75505649 |
| 93 | MP0000751_myopathy | 0.72907753 |
| 94 | MP0005377_hearing/vestibular/ear_phenot | 0.72636599 |
| 95 | MP0003878_abnormal_ear_physiology | 0.72636599 |
| 96 | MP0008874_decreased_physiological_sensi | 0.72189733 |
| 97 | MP0005499_abnormal_olfactory_system | 0.72177861 |
| 98 | MP0005394_taste/olfaction_phenotype | 0.72177861 |
| 99 | MP0005379_endocrine/exocrine_gland_phen | 0.69589226 |
| 100 | MP0003879_abnormal_hair_cell | 0.69398611 |
| 101 | MP0006292_abnormal_olfactory_placode | 0.68143924 |
| 102 | MP0000647_abnormal_sebaceous_gland | 0.67919510 |
| 103 | MP0005410_abnormal_fertilization | 0.67804288 |
| 104 | MP0000537_abnormal_urethra_morphology | 0.66932078 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.66045690 |
| 106 | MP0002249_abnormal_larynx_morphology | 0.66033683 |
| 107 | MP0002751_abnormal_autonomic_nervous | 0.65175161 |
| 108 | MP0002234_abnormal_pharynx_morphology | 0.63692699 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.63089383 |
| 110 | MP0000579_abnormal_nail_morphology | 0.61043558 |
| 111 | MP0001986_abnormal_taste_sensitivity | 0.60754898 |
| 112 | MP0006276_abnormal_autonomic_nervous | 0.60460481 |
| 113 | MP0002928_abnormal_bile_duct | 0.59520180 |
| 114 | MP0005195_abnormal_posterior_eye | 0.59341709 |
| 115 | MP0005595_abnormal_vascular_smooth | 0.59082431 |
| 116 | MP0002127_abnormal_cardiovascular_syste | 0.58704318 |
| 117 | MP0003119_abnormal_digestive_system | 0.57511858 |
| 118 | MP0010770_preweaning_lethality | 0.56599761 |
| 119 | MP0002082_postnatal_lethality | 0.56599761 |
| 120 | MP0010769_abnormal_survival | 0.56501822 |
| 121 | MP0009384_cardiac_valve_regurgitation | 0.56205172 |
| 122 | MP0004085_abnormal_heartbeat | 0.56142067 |
| 123 | MP0008872_abnormal_physiological_respon | 0.55154133 |
| 124 | MP0000462_abnormal_digestive_system | 0.53301609 |
| 125 | MP0001943_abnormal_respiration | 0.51713455 |
| 126 | MP0001664_abnormal_digestion | 0.51581294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.00794621 |
| 2 | Focal motor seizures (HP:0011153) | 5.81233197 |
| 3 | Megalencephaly (HP:0001355) | 5.80244661 |
| 4 | Aplasia involving bones of the upper limbs (HP:0009823) | 5.56964186 |
| 5 | Aplasia of the phalanges of the hand (HP:0009802) | 5.56964186 |
| 6 | Aplasia involving bones of the extremities (HP:0009825) | 5.56964186 |
| 7 | Myokymia (HP:0002411) | 4.74875056 |
| 8 | Cerebral inclusion bodies (HP:0100314) | 4.70697075 |
| 9 | Epileptic encephalopathy (HP:0200134) | 4.51202929 |
| 10 | Clumsiness (HP:0002312) | 3.85148114 |
| 11 | Focal seizures (HP:0007359) | 3.82041008 |
| 12 | Hyperventilation (HP:0002883) | 3.64657870 |
| 13 | Hemiparesis (HP:0001269) | 3.63990562 |
| 14 | Abnormality of binocular vision (HP:0011514) | 3.63195685 |
| 15 | Diplopia (HP:0000651) | 3.63195685 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.52696788 |
| 17 | Broad-based gait (HP:0002136) | 2.92470945 |
| 18 | Action tremor (HP:0002345) | 2.91961266 |
| 19 | Dysdiadochokinesis (HP:0002075) | 2.91053023 |
| 20 | Dysmetria (HP:0001310) | 2.75161584 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 2.71963833 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 2.71817011 |
| 23 | Truncal ataxia (HP:0002078) | 2.66414398 |
| 24 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.65444012 |
| 25 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.65444012 |
| 26 | Cerebral hypomyelination (HP:0006808) | 2.63280911 |
| 27 | Hemiplegia (HP:0002301) | 2.62276825 |
| 28 | Thickened helices (HP:0000391) | 2.62136933 |
| 29 | Hypoplastic left heart (HP:0004383) | 2.61537095 |
| 30 | Split foot (HP:0001839) | 2.58221235 |
| 31 | Synostosis involving the elbow (HP:0003938) | 2.57752373 |
| 32 | Humeroradial synostosis (HP:0003041) | 2.57752373 |
| 33 | Abnormality of secondary sexual hair (HP:0009888) | 2.57070360 |
| 34 | Abnormality of the axillary hair (HP:0100134) | 2.57070360 |
| 35 | Dialeptic seizures (HP:0011146) | 2.52942571 |
| 36 | Atonic seizures (HP:0010819) | 2.50175628 |
| 37 | Febrile seizures (HP:0002373) | 2.46159469 |
| 38 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.46048075 |
| 39 | Mutism (HP:0002300) | 2.45974207 |
| 40 | Abnormality of the labia minora (HP:0012880) | 2.43291158 |
| 41 | Intention tremor (HP:0002080) | 2.41271426 |
| 42 | Alacrima (HP:0000522) | 2.38689579 |
| 43 | Abnormality of the corticospinal tract (HP:0002492) | 2.37076481 |
| 44 | Abnormal eating behavior (HP:0100738) | 2.36005401 |
| 45 | Status epilepticus (HP:0002133) | 2.35662371 |
| 46 | Scanning speech (HP:0002168) | 2.32753782 |
| 47 | Ankle clonus (HP:0011448) | 2.31523138 |
| 48 | Spastic gait (HP:0002064) | 2.31324391 |
| 49 | Absence seizures (HP:0002121) | 2.31010689 |
| 50 | Visual hallucinations (HP:0002367) | 2.25029889 |
| 51 | Long nose (HP:0003189) | 2.24928128 |
| 52 | Medial flaring of the eyebrow (HP:0010747) | 2.24745278 |
| 53 | Septo-optic dysplasia (HP:0100842) | 2.23419327 |
| 54 | Congenital primary aphakia (HP:0007707) | 2.23220466 |
| 55 | True hermaphroditism (HP:0010459) | 2.22019236 |
| 56 | Anteriorly placed anus (HP:0001545) | 2.21775508 |
| 57 | Mixed hearing impairment (HP:0000410) | 2.21750384 |
| 58 | Lower limb muscle weakness (HP:0007340) | 2.21209244 |
| 59 | Postural instability (HP:0002172) | 2.20953288 |
| 60 | Amyotrophic lateral sclerosis (HP:0007354) | 2.20259858 |
| 61 | Gaze-evoked nystagmus (HP:0000640) | 2.19055543 |
| 62 | Genital tract atresia (HP:0001827) | 2.18753237 |
| 63 | Peripheral hypomyelination (HP:0007182) | 2.18617686 |
| 64 | Vaginal atresia (HP:0000148) | 2.17717561 |
| 65 | Specific learning disability (HP:0001328) | 2.16424445 |
| 66 | Impaired social interactions (HP:0000735) | 2.14704366 |
| 67 | Abnormal social behavior (HP:0012433) | 2.14704366 |
| 68 | Sleep apnea (HP:0010535) | 2.13634934 |
| 69 | Anxiety (HP:0000739) | 2.12718043 |
| 70 | Abnormality of the dental pulp (HP:0006479) | 2.11757331 |
| 71 | Depression (HP:0000716) | 2.07497492 |
| 72 | Polyphagia (HP:0002591) | 2.07056432 |
| 73 | Absent speech (HP:0001344) | 2.04659084 |
| 74 | Optic nerve hypoplasia (HP:0000609) | 2.04585038 |
| 75 | Epileptiform EEG discharges (HP:0011182) | 2.04433679 |
| 76 | Retinal dysplasia (HP:0007973) | 2.03111432 |
| 77 | Termporal pattern (HP:0011008) | 2.02632421 |
| 78 | Insidious onset (HP:0003587) | 2.02632421 |
| 79 | Hypoplastic heart (HP:0001961) | 2.02587340 |
| 80 | Blue irides (HP:0000635) | 2.01737989 |
| 81 | Nephrogenic diabetes insipidus (HP:0009806) | 2.01638214 |
| 82 | Rigidity (HP:0002063) | 2.00044713 |
| 83 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.98812883 |
| 84 | Abnormality of the lower motor neuron (HP:0002366) | 1.98562007 |
| 85 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.97975783 |
| 86 | EEG with generalized epileptiform discharges (HP:0011198) | 1.97681203 |
| 87 | Drooling (HP:0002307) | 1.96978527 |
| 88 | Excessive salivation (HP:0003781) | 1.96978527 |
| 89 | Akinesia (HP:0002304) | 1.96136037 |
| 90 | Incomplete penetrance (HP:0003829) | 1.91664857 |
| 91 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.90934063 |
| 92 | Back pain (HP:0003418) | 1.90528151 |
| 93 | Short hallux (HP:0010109) | 1.90381207 |
| 94 | Narrow nasal bridge (HP:0000446) | 1.89717182 |
| 95 | Decreased lacrimation (HP:0000633) | 1.89126714 |
| 96 | Coronal craniosynostosis (HP:0004440) | 1.88577947 |
| 97 | Stereotypic behavior (HP:0000733) | 1.88507465 |
| 98 | Hypsarrhythmia (HP:0002521) | 1.87503111 |
| 99 | Pheochromocytoma (HP:0002666) | 1.86707197 |
| 100 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.86357882 |
| 101 | Inability to walk (HP:0002540) | 1.85856157 |
| 102 | Spastic tetraparesis (HP:0001285) | 1.84615931 |
| 103 | Delusions (HP:0000746) | 1.84400042 |
| 104 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.83607623 |
| 105 | Generalized myoclonic seizures (HP:0002123) | 1.83605728 |
| 106 | Leukodystrophy (HP:0002415) | 1.83425162 |
| 107 | Gait imbalance (HP:0002141) | 1.83109147 |
| 108 | Poor eye contact (HP:0000817) | 1.82742869 |
| 109 | Bradykinesia (HP:0002067) | 1.81764517 |
| 110 | Focal dystonia (HP:0004373) | 1.79811074 |
| 111 | Taurodontia (HP:0000679) | 1.79731209 |
| 112 | Abnormality of permanent molar morphology (HP:0011071) | 1.79731209 |
| 113 | Abnormality of the dental root (HP:0006486) | 1.79731209 |
| 114 | CNS hypomyelination (HP:0003429) | 1.77178314 |
| 115 | Urinary urgency (HP:0000012) | 1.76997940 |
| 116 | Impaired smooth pursuit (HP:0007772) | 1.76093282 |
| 117 | Pancreatic fibrosis (HP:0100732) | 1.75936801 |
| 118 | Neuronal loss in central nervous system (HP:0002529) | 1.75822739 |
| 119 | Decreased central vision (HP:0007663) | 1.75745783 |
| 120 | Abnormality of molar (HP:0011077) | 1.74672165 |
| 121 | Abnormality of molar morphology (HP:0011070) | 1.74672165 |
| 122 | Clonus (HP:0002169) | 1.74546014 |
| 123 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.74434253 |
| 124 | Confusion (HP:0001289) | 1.73535948 |
| 125 | Paraparesis (HP:0002385) | 1.73242899 |
| 126 | Torticollis (HP:0000473) | 1.73101774 |
| 127 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.72487310 |
| 128 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.71925906 |
| 129 | Absent hair (HP:0002298) | 1.71390885 |
| 130 | Limb dystonia (HP:0002451) | 1.69994057 |
| 131 | Impaired vibratory sensation (HP:0002495) | 1.69514592 |
| 132 | Bronchomalacia (HP:0002780) | 1.68905431 |
| 133 | Sensory axonal neuropathy (HP:0003390) | 1.68719025 |
| 134 | Amblyopia (HP:0000646) | 1.67892553 |
| 135 | Slow saccadic eye movements (HP:0000514) | 1.65653767 |
| 136 | Partial duplication of thumb phalanx (HP:0009944) | 1.65168606 |
| 137 | Cutaneous finger syndactyly (HP:0010554) | 1.63600081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.20907677 |
| 2 | CASK | 3.89302824 |
| 3 | TNIK | 3.40114756 |
| 4 | NTRK2 | 2.85813700 |
| 5 | PHKG2 | 2.82659471 |
| 6 | PHKG1 | 2.82659471 |
| 7 | NTRK3 | 2.80344894 |
| 8 | LMTK2 | 2.41180932 |
| 9 | MARK1 | 2.29797329 |
| 10 | PRKD3 | 2.01057558 |
| 11 | MUSK | 2.00621620 |
| 12 | MAP3K4 | 1.84088464 |
| 13 | OXSR1 | 1.83288899 |
| 14 | MAP2K7 | 1.81399767 |
| 15 | MAP3K9 | 1.77924203 |
| 16 | PRPF4B | 1.76127200 |
| 17 | MAPK13 | 1.68285396 |
| 18 | DAPK2 | 1.66957448 |
| 19 | NTRK1 | 1.59443300 |
| 20 | FGFR2 | 1.59379606 |
| 21 | SGK494 | 1.53959507 |
| 22 | SGK223 | 1.53959507 |
| 23 | MINK1 | 1.53097438 |
| 24 | CDK19 | 1.52817537 |
| 25 | STK39 | 1.51507936 |
| 26 | PAK6 | 1.41804646 |
| 27 | RIPK4 | 1.34378934 |
| 28 | CDK5 | 1.29111691 |
| 29 | DYRK2 | 1.28244455 |
| 30 | MAPK15 | 1.21280741 |
| 31 | PKN1 | 1.19448386 |
| 32 | WNK3 | 1.15527697 |
| 33 | KSR2 | 1.15487926 |
| 34 | MAP3K13 | 1.14443094 |
| 35 | SGK2 | 1.08197907 |
| 36 | CAMK2A | 1.07167488 |
| 37 | EPHB2 | 1.07143166 |
| 38 | PRKCG | 1.03213577 |
| 39 | MAPK12 | 1.01448881 |
| 40 | CAMK2B | 0.99924874 |
| 41 | FGR | 0.98309172 |
| 42 | TYRO3 | 0.98083911 |
| 43 | MAP2K4 | 0.96618974 |
| 44 | FRK | 0.94466642 |
| 45 | MAP4K2 | 0.91789289 |
| 46 | PLK2 | 0.91400509 |
| 47 | CAMKK1 | 0.89302345 |
| 48 | SGK3 | 0.87029174 |
| 49 | ADRBK2 | 0.85698396 |
| 50 | KSR1 | 0.83064587 |
| 51 | CSNK1G3 | 0.81275045 |
| 52 | PRKCE | 0.81191099 |
| 53 | CAMKK2 | 0.80626020 |
| 54 | UHMK1 | 0.79704847 |
| 55 | CSNK1G2 | 0.75594071 |
| 56 | ARAF | 0.74253778 |
| 57 | CDK15 | 0.74237812 |
| 58 | ROCK2 | 0.74068148 |
| 59 | CDK18 | 0.73555872 |
| 60 | PNCK | 0.73493150 |
| 61 | CSNK1G1 | 0.72949954 |
| 62 | MAPK7 | 0.70727067 |
| 63 | MAPKAPK5 | 0.70528351 |
| 64 | BMPR2 | 0.70365274 |
| 65 | DYRK1A | 0.70213871 |
| 66 | LATS2 | 0.69725192 |
| 67 | PINK1 | 0.69597425 |
| 68 | NEK6 | 0.68997752 |
| 69 | SGK1 | 0.68316586 |
| 70 | CAMK2G | 0.67629195 |
| 71 | ADRBK1 | 0.65659135 |
| 72 | BMPR1B | 0.65285760 |
| 73 | CDK14 | 0.64719465 |
| 74 | SIK1 | 0.63613727 |
| 75 | DMPK | 0.63361078 |
| 76 | CDK11A | 0.63345760 |
| 77 | CAMK2D | 0.62795932 |
| 78 | PAK3 | 0.62115829 |
| 79 | PRKCH | 0.61939996 |
| 80 | MARK2 | 0.59800201 |
| 81 | CAMK4 | 0.58070746 |
| 82 | TSSK6 | 0.57810871 |
| 83 | ERBB2 | 0.57730076 |
| 84 | FES | 0.56396643 |
| 85 | CCNB1 | 0.54824095 |
| 86 | MKNK2 | 0.53259350 |
| 87 | INSRR | 0.53186122 |
| 88 | PDPK1 | 0.52857819 |
| 89 | GRK5 | 0.51082057 |
| 90 | STK11 | 0.50886385 |
| 91 | CDK3 | 0.49690736 |
| 92 | CAMK1 | 0.49279175 |
| 93 | MAP3K7 | 0.49163857 |
| 94 | SIK2 | 0.48748640 |
| 95 | GRK1 | 0.48667671 |
| 96 | PTK2B | 0.48273547 |
| 97 | DAPK1 | 0.47863125 |
| 98 | CSNK1A1 | 0.47538296 |
| 99 | PRKCQ | 0.46862399 |
| 100 | MAP3K2 | 0.46817982 |
| 101 | PRKG1 | 0.45979282 |
| 102 | RAF1 | 0.43359256 |
| 103 | RPS6KA3 | 0.42966258 |
| 104 | WEE1 | 0.41956940 |
| 105 | MAPK10 | 0.41571905 |
| 106 | MAP3K12 | 0.40536652 |
| 107 | PRKACA | 0.40510522 |
| 108 | WNK1 | 0.40236908 |
| 109 | LIMK1 | 0.40203388 |
| 110 | DYRK3 | 0.40202375 |
| 111 | AKT3 | 0.39367427 |
| 112 | FYN | 0.39042250 |
| 113 | CSNK1D | 0.38797313 |
| 114 | PRKCA | 0.38221191 |
| 115 | ROCK1 | 0.37355249 |
| 116 | CSNK1A1L | 0.37337177 |
| 117 | PDK1 | 0.36551539 |
| 118 | PRKCZ | 0.36365913 |
| 119 | BCR | 0.36015521 |
| 120 | CAMK1G | 0.35898838 |
| 121 | PRKACB | 0.35296759 |
| 122 | RET | 0.34262429 |
| 123 | GRK6 | 0.32514465 |
| 124 | CSNK1E | 0.30187839 |
| 125 | PRKCB | 0.27801830 |
| 126 | PLK3 | 0.27267089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.21889747 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.27111730 |
| 3 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.88997403 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.52390503 |
| 5 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.41321875 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.28584898 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.25320358 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.23653815 |
| 9 | Salivary secretion_Homo sapiens_hsa04970 | 2.12389071 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.07642153 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 1.98450260 |
| 12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.92565360 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.89448182 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.78192455 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.78035717 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.75736882 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.75417556 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.62425094 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54233939 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.42975137 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.42251134 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40547439 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.39836398 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.39085581 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.39060822 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.35463845 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33957399 |
| 28 | * Cocaine addiction_Homo sapiens_hsa05030 | 1.29027446 |
| 29 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.27598595 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23653124 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22859262 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22715098 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18961964 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.18673682 |
| 35 | Axon guidance_Homo sapiens_hsa04360 | 1.16986476 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.15141225 |
| 37 | Parkinsons disease_Homo sapiens_hsa05012 | 1.14592132 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.14471466 |
| 39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.12151233 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10980475 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.05833704 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.05669092 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.05421043 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.01568172 |
| 45 | Circadian rhythm_Homo sapiens_hsa04710 | 1.00475643 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99233912 |
| 47 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98800874 |
| 48 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97949180 |
| 49 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92872832 |
| 50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92435918 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92312666 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92291338 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90962844 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.90180444 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85215217 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84919442 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84000814 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83903859 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82827538 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.81441608 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80850575 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.78767062 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77488945 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75966563 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74401448 |
| 66 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72576615 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72184623 |
| 68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70884529 |
| 69 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70671572 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69891727 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68406577 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67553953 |
| 73 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.66771513 |
| 74 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64878065 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64843076 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64748615 |
| 77 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64651762 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.62241118 |
| 79 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61929714 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59893108 |
| 81 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59668339 |
| 82 | Protein export_Homo sapiens_hsa03060 | 0.58003055 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57521801 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57274082 |
| 85 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.57265635 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.56680873 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.55978360 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.55515440 |
| 89 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55414213 |
| 90 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53710711 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.53460495 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53436335 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53337317 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51646450 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50324949 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49842802 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47488978 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47122053 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46748201 |
| 100 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46025598 |
| 101 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45906414 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45011110 |
| 103 | Phototransduction_Homo sapiens_hsa04744 | 0.43596186 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43214848 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43032274 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38037764 |
| 107 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.35990521 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35793420 |
| 109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33907718 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33663459 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33597847 |
| 112 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33433231 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32736102 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32178685 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.30725459 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29489652 |
| 117 | Peroxisome_Homo sapiens_hsa04146 | 0.23615543 |

